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Abstract— Dementia is one of the most feared illnesses that 
has a growing year-to-year negative global impact, having a 
health and social care cost higher than cancer, stroke and 
chronic heart disease, taken together. Without the availability 
of a cure, nor a standardised clinical test, the utilisation of 
machine learning methods to identify individuals that are at risk 
of developing dementia could bring a new step towards 
proactive intervention. This study’s goal is to carry out a 
precursor analysis leading to building classification models with 
enhanced capabilities for differentiating diagnoses of CN 
(Cognitively Normal), MCI (Mild Cognitive Impairment) and 
Dementia. The predictive modelling approach we propose is 
based on the ReliefF method combined with statistical 
permutation tests for feature selection, and on model training, 
tuning, and testing based on algorithms such as Random 
Forests, Support Vector Machines, Gaussian Processes, 
Stochastic Gradient Boosting, and eXtreme Gradient Boosting. 
Stability of model performances were studied in 
computationally intensive Monte Carlo simulations. The results 
consistently show that our models accurately detect dementia, 
and also mild cognitive impairment patients by only using the 
inclusion of baseline measurements as predictors, thus 
illustrating the importance of baseline measurements. The best 
results issued from Monte Carlo were achieved by eXtreme 
Gradient Boosting optimised models, with an accuracy of 0.88 
(SD 0.02), a sensitivity of 0.93 (SD 0.02) and a specificity of 0.94 
(SD 0.01) for dementia, and a sensitivity of 0.86 (SD 0.02) and a 
specificity of 0.9 (SD 0.02) for mild cognitive impairment. These 
results support in particular future developments for a risk-
based method that can identify an individual’s risk of 
developing dementia. 
Keywords— Dementia, Machine Learning, ReliefF, 
Statistical Permutation Tests, Support Vector Machines, 
Gaussian Processes, Stochastic Gradient Boosting, eXtreme 
Gradient Boosting, Monte Carlo Simulations 
I. INTRODUCTION 
Being the most feared illness of people over the 
age of 55 [1], dementia has been described as “…a 
syndrome (essentially brain failure) affecting 
higher functions of the brain” [1]. By the year 2050 
there will be a worldwide estimated 131.5 million 
people who will be living with dementia and by 
2030 it will have an associated worldwide cost of 2 
trillion US dollars [2]. For comparison, dementia 
has currently a health and social care cost higher 
than cancer, stroke and chronic heart disease, taken 
together. 
Diagnosis is problematic because there is 
currently no standardized ‘dementia test’ and the 
diagnosis of dementia is a highly specified task 
based on the possible sub-types of dementia, as well 
as various means of cognitive assessment [1]. 
Additionally, those that are diagnosed with mild 
cognitive impairment (MCI), while having a 
substantially higher risk of developing dementia 
[3], can either become cognitively stable or return 
to a healthy cognitive norm [4]. These complexities 
have led to a large majority of people with dementia 
to go undiagnosed, and even with a successful 
diagnosis, there is no cure [1]. Therefore, the 
development of effective methods is crucial for 
early at-risk identification and proactive 
interventions [5,6]. 
Machine learning implementation in the 
healthcare sector can provide an efficient means of 
using complex information to accurately predict 
diagnoses. The size and convolution of DNA 
sequences have been increasing in recent years; 
however, supervised machine learning methods, 
like a Bayesian Hidden Markov model, have been 
used to interpret DNA sequences for cancer 
prediction [7]. Feature selection methods, in 
combination with classification models, have been Daniel Stamate was partly funded by Alzheimer’s Research UK 
(ARUK) – ‘Predicting risk of dementia using routine primary care records’ 
grant, and Goldsmiths, University of London.  
used to identify critical variables and produce high 
performing models that are able to distinguish 
between different ‘wheeze’ categories in young 
children, for asthma research [8]. Dementia shares 
these complexities and the combination of Medical 
and Computer Science specialities will benefit 
research greatly.  
With the goal of moving away from a ‘one-size 
fits all’ approach to dementia prediction [13], the 
inclusion of machine learning methods enables the 
utilization of various data sources and predictive 
variables. There are hundreds of possible 
predictors, but they can generally be categorized 
based on the following applicable models: 
neuropsychological based models, health-based 
models, multifactorial models and genetic risk 
scores [13]. However, there is still large amount 
deviance in the application of these models [9-12]. 
The use of magnetic resonance imaging (MRI), in 
combination with multiplex neural networks, has 
been used to segregate healthy brains from 
progressive mild cognitive impairment (pMCI), 
based on the structural atrophy of the brain because 
of Alzheimer’s [9]. United Kingdom’s General 
Practitioner (GP) patient records have been used to 
develop a risk score for the purposes of estimating 
how at risk an individual may be of developing 
dementia [10]. Genetic markers have been used to 
create a ‘polygenic hazard score test’, where the 
results of the test indicate how likely a person is to 
developing Alzheimer’s over the course of the 
study [11]. Positron emission tomography (PET) 
scans and the regional analysis of the protein 
amyloid-β, have been used by a Random Forest 
classifier to identify patients with age-related stable 
MCI and pMCI [12].  
Risk scores are of use because these enable 
primary care facilitators to have an estimation of 
how at-risk an individual is of developing dementia. 
Once an individual is identified with a high 
probability of developing dementia, then proactive 
lifestyle interventions can be adopted to curb the 
development of this disease. Proven methods, such 
as the Finnish Geriatric Intervention Study to 
Prevent Cognitive Impairment and Disability 
(FINGER), have illustrated how multidomain 
interventions (diet, exercise, vascular monitoring 
and cognitive training) could improve primary and 
secondary cognitive performance with age and 
reduce the risk of dementia [14]. This can be further 
extrapolated on with the advent of a mobile 
application that has users provide their information 
and yields the resulting risk score with intervention 
suggestions [15]. However, an idea such as this 
must be grounded in verifiable and validated 
methodologies. 
The focus on risk score methodology 
development has resulted in a widespread effort 
with more than 50 different dementia risk scores in 
2010 [16]. However, a systematic review of these 
models has concluded that no single method could 
be recommended for a generalized screening 
procedure due to methodological weaknesses (e.g. 
population biases and lack of external validation) 
[17]. This has spurred an emphasis on analysing 
existing research to inform future work’s feature 
selection, for instance, the inclusion of predictors 
such as: depression, anxiety, cognitive symptoms 
and others that are positively associated with 
dementia [18].  
 The work we propose here is the initial process 
for the development of a risk score methodology, 
which extrapolates on the feature selection process 
and is flexible enough to be generalized to different 
cohorts. This is accomplished by conducting the 
preliminary analysis on Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) data and assessing 
the predictive power of the variables provided, as 
well as predictive capabilities for trained and 
optimised classification models that we propose. As 
such, this study’s goal is to carry out a precursor 
analysis that utilises feature selection to identify 
variables with large predictive capabilities and 
determining the capacity that classification models 
have on differentiating diagnoses of CN 
(Cognitively Normal), MCI (Mild Cognitive 
Impairment) and Dementia. Information gain and 
ReliefF methods are alternatively used for feature 
selection. Model training, tuning, and testing are 
performed with cross-validation and are based on 
algorithms such as: Random Forests, Support 
Vector Machines, Gaussian Processes, Stochastic 
Gradient Boosting, and eXtreme Gradient 
Boosting. Stability of model performances are 
studied using Monte Carlo simulations. From the 
promising results that we present in this work, 
future research will be conducted for the adaptation 
of this framework into a generalized, individual risk 
score through methods like the Disease State Index 
(DSI) [19]. 
The rest of the paper is organised as follows. In 
Section II we describe the data and the machine 
learning based predictive modelling methodology 
that we devised for this study. Section III discusses 
the results, and section IV provides the conclusions 
and indicates future work directions.  
II. METHODS 
A. Alzheimer’s Disease Neuroimaging Initiative  
Data used in this study was extracted from the 
Alzheimer’s Disease Neuroimaging Initiative 
(ADNI) database (adni.loni.usc.edu). The ADNI 
study was launched in 2003 by the National 
Institute on Aging (NIA), the National Institute of 
Biomedical Imaging and Bioengineering (NIBIB), 
the Food and Drug Administration (FDA), private 
pharmaceutical companies and non-profit 
organizations, as a $60 million dollar, 5-year, 
public-private partnership. The primary goal of 
ADNI study has been to test whether serial 
magnetic resonance imaging (MRI), positron 
emission tomography (PET), other biological 
markers, clinical and neuropsychological 
assessments could be combined to create impactful 
research into dementia.    
Data used in this work was downloaded on 6th 
May 2018 from the ADNIMERGER R package 
[20]. The adnimerge dataset merges together 
several key variables from various case report 
forms and biomarker lab from all ADNI protocols 
(ADNI1, ADNIGO, and ADNI2). The integrated 
data consists of 113 variables and 13272 
observations, which include multiple observations 
per participant, representing multiple visits to the 
study’s site for participant evaluation (up to 20 
visits per participant). The data that is used in this 
study is a subset of the adnimerge data that contains 
only baseline variable measurements (i.e. the first 
visit for each participant) that have a diagnosis. The 
resulting data contains 1851 participants, 49 input 
attributes, and one output attribute. The outcome 
variable ‘DX’ has the three distinct classes, which 
are CN (Cognitive Normal), MCI (Mild Cognitive 
Impairment), and Dementia.  In this paper and 
analysis, 75% of the data were used for building and 
optimising prediction models, and the remaining 
25% comprised the testing set to evaluate the 
performance of the models.   
B. Description of variables 
The variables extracted from the original dataset 
were as follows:   
• Baselines Demographics: age, gender, 
ethnicity, race, marital status, and education level 
were included as predictors.  Demographic 
variables with nominal values (e.g. gender, 
ethnicity and race) were dummified to numeric 
format.   
• Functional Activities Questionnaire 
(FAQ) is a test that can be used to assess the 
dependency on another person that a participant 
requires to carry out normal daily tasks.  FAQ 
consists of questionnaires and multiple choice 
questions, which are given to yield an aggregate 
score from 0 to 30.  
• Mini-Mental State Exam (MMSE) is used 
to estimate the severity and progression of cognitive 
impairment and to follow the course of cognitive 
changes in an individual over time.  
• PET measurements (FDG, PIB, AV45) are 
participant’s brain function measurements. 
• MRI measurements (Hippocampus, 
intracranial volume (ICV), MidTemp, Fusiform, 
Ventricles, Entorhinal and WholeBrain) are 
structural measurements of a participant’s brain.   
• APOE4 is an integer measurement 
representing the appearance of epsilon 4 allele of 
the APOE gene.      
• Variables ‘ABETA’, ‘TAU’, ‘PTAU’ are 
cerebrospinal fluid (CSF) biomarker 
measurements.   
• Rey's Auditory Verbal Learning Test 
(RAVLT) are neurophysiological tests evaluating 
an individual’s episodic memory.  
• Everyday cognitive evaluations (Ecog) are 
questionnaires that illustrates a participant’s ability 
to carry out everyday tasks. 
• Logical Memory – Delayed Recall Total 
Number of Story Units Recalled (LDELTOTAL) 
is a neuropsychological test that evaluates a 
person’s ability to recall information after a 
prescribed amount of time. 
• Modified Preclinical Alzheimer Cognitive 
Composite (mPACC) are tests that evaluate a 
person’s cognition, episodic memory and timed 
executive function. 
• ADAS and MOCA are generalized 
neuropsychological tests that evaluate a person’s 
cognitive ability (e.g. memory, visuospatial, etc.).   
• Variables ‘Phase’, ‘RID’, ‘VISCODE’ are 
used as unique primary keys to merge the datasets. 
C. Feature selection 
Feature selection is the process of selecting a 
subset of relevant features for the building of 
more accurate models. It helps to reduce 
overfitting [21], enables machine learning 
algorithms to train faster and reduces the 
complexity of models, which makes 
interpretation easier. Using all the 49 attributes 
in the experiments cost a negative impact on 
some machine learning algorithms such as 
Support Vector Machines. Therefore, to select a 
desired set of predictors, two feature selection 
methods were alternatively employed in this 
study:  
 We simply select the attributes that score at 
least 0.01 in information gain.  
 ReliefF feature selection combined by us 
with statistical permutation tests based on 
500 random permutations of the labels, was 
employed similarly to the implementation in 
[8]. For instance, features with an observed 
Relief score corresponding to a distance of at 
least 1.96 standard deviations from the 
centre of the normal distribution built with 
the Relief scores, repeatedly calculated 500 
times with permuted labels, were selected 
for further processing. This was based on the 
application of the permutation test with 
significance level alpha=0.05. The example 
of such a variable (mPACCdigit.bl) is 
indicated in Figure 1. The analysis in our 
study was performed for each of the alpha 
values 0.01, 0.05, 0.1, and 0.2, to select the 
one leading to the best prediction 
performances.  
FIGURE 1. THE DASHED LINE CORRESPONDING TO 
OBSERVED RELIEF SCORE=0.38 FOR MPACCDIGIT.BL 
VARIABLE IS SUFFICIENTLY FAR AWAY FROM THE 
CENTRE OF THE NORMAL DISTRIBUTION OF THE 
VARIABLE’S RELIEF SCORES BASED ON 500 
PERMUTATIONS OF LABELS, IN ORDER TO INDICATE 
SIGNIFICANT PREDICTIVE POWER FOR MPACCDIGIT.BL. 
 
As part of our objectives, we would like to gain 
a deeper understanding of which variables have 
strong associations to the classes, to be used as 
practical clinical information. This was achieved by 
implemeting, as previously mentioned, feature 
selection methods with several prediction models 
and the results were then compared. 
D. Missing Value Imputation 
Missing values are imputed by using the random 
forest imputation from the randomForest package 
[22]. Although this method is computationally 
expensive, it enhanced the predictive power of the 
final models.  
E. Balancing Classes 
Large class imbalance has often a negative 
impact on the performance of classification models, 
as the algorithms producing them tend to focus 
more on detecting the dominant class, and less on 
detecting the minority class. In other words, 
sensitivity for the smallest class is most often 
negatively affected. The class distribution for our 
data is as follows: CN: 617, MCI: 886, Dementia: 
348, which suggests that without applying a remedy 
solution to treat the class imbalance, the minority 
class Dementia could be poorly detected by the 
classification models. The so called synthetic 
minority over-sampling technique SMOTE [23] 
was selected to treat this class imbalance problem. 
SMOTE chooses a data point randomly from the 
minority class, determines the K nearest neighbours 
to that point and then uses these neighbours to 
generate new synthetic data points using an 
interpolation of said neighbours. The synthetic data 
was added to the minority class to overcome the gap 
between the majority and minority classes in terms 
of number of instances. Our analysis used 5 
neighbours. This technique is to be applied only on 
the training set as it shouldn’t affect the distribution 
of classes in the test set.  
F. Tuning Predictive Models 
To develop optimised predictive models in our 
study, we controlled the parameter values for each 
of the considered algorithms using chosen grids. 
Predictive models have been fitted with a 10-fold 
cross-validation procedure on the training set, after 
pre-processing techniques were applied on the same 
training set. Models were then evaluated on the test 
set.  
Models were based on the following algorithms: 
Random Forests, Support Vector Machines, 
Gaussian Processes, Stochastic Gradient Boosting, 
and eXtreme Gradient Boosting. 
Firstly, Random Forests models were tuned over 
the values 2, 4, 6, …, 48 for ‘Mtry’ (the number of 
attributes competing in a node) and a fixed number 
of 500 trees. A value of 38 was found as optimal for 
the Mtry parameter. 
Secondly, Support Vector Machines models 
were tuned with linear and radial kernels. The 
optimal Support Vector Machine models were 
obtained after tuning the parameters ‘cost’ and 
‘gamma’ with over 32 distinct values. The optimal 
values for cost and gamma were 16 and 0.0161, 
respectively. 
Thirdly, Gaussian Processes models were tuned 
with linear and radial kernels. The optimal 
Gaussian Processes models were obtained with a 
radial kernel and a value of 0.0312 for gamma, 
which was tuned over 10 values.  
Fourthly, Stochastic Gradient Boosting models 
were tuned with a different number of trees to fit, 
maximum depth, minimum number of 
observations in the tree’s terminal nodes and 
shrinkage (learning rate). The optimal values were, 
respectively, 100, 8, 10 and 0.1. 
Finally, the tuning parameters for eXtreme 
Gradient Boosting were: the number of rounds for 
boosting iteration, maximum depth, shrinkage 
(learning rate), gamma (Minimum Loss 
Reduction), subsample ratio of columns, minimum 
sum of instance weight and the subsample 
percentage. The optimal values were 100, 4, 0.1, 0, 
0.7, 1 and 0.5, respectively. 
G. Monte Carlo simulation 
The stability of well performing models was 
investigated using a Monte Carlo simulation. This 
method repeatedly involves randomly splitting the 
dataset in training and test datasets, and rebuilding 
and retesting the models to illustrate the variance in 
model performance. In our case we repeated the 
process 100 times. Performance metrics of: 
accuracy, Cohen’s kappa statistic, sensitivity (with 
respect to each class) and specificity (with respect 
to each class), were evaluated and recorded with 
each Monte Carlo iteration. In addition, in each 
Monte Carlo iteration we record also the area under 
the curve (AUC) for each class versus the rest. 
Due to lack of space, the results were visualised 
only for class Dementia, using boxplots to capture 
model performance capability and stability, for the 
3 best performing models. Performances for all 
classes issued from Monte Carlo were captured in 
tables, in an aggregated form, as average 
performance and standard deviation (SD)  
H. Hardware and software 
The Monte Carlo simulation in this study 
included model optimisation as part of a 10 cross-
validation, which results in a computationally 
expensive procedure. This was implemented in a 
parallel processing which was performed on a data 
analytics cluster of 11 servers with Xeon processors 
and 832GB fast RAM. The R software was used 
with a number of packages, including caret, pROC, 
xgboost, e1071, CORElearn, randomForest, plyr, 
data.table, AppliedPredictiveModeling, DMwR and 
doParallel. 
III. RESULTS 
The top performing 15 models were based on 
decision trees algorithms, such as: Random Forest, 
Stochastic Gradient Boosting, and eXtreme 
Gradient Boosting. Many models built with 
Gaussian Process, and Support Vector Machines 
algorithms also achieved satisfactory results. This 
confirms that there exists a significantly strong 
pattern in the data, as several different techniques 
were able to capture it. 
The best performing feature selection technique 
was the ReliefF method with alpha = 0.1; therefore, 
it was our primary feature selection method in this 
study.  
The best result was produced by an eXtreme 
Gradient Boosting model, with feature selection 
performed by the ReliefF method. This feature 
selection method included only variables with an 
observed Relief score corresponding to a p-value 
lower than 0.1 in the statistical permutation test. 
The second-best result was achieved by a Stochastic 
Gradient Boosting model that used the same 
variables as the model just described.  The third best 
performer was Random Forest, using the same 
variables mentioned. The performances of the best 
3 models are displayed in Tables I, II, and III. 
TABLE I.  3 TOP PERFORMING MODELS WRT ACCURACY 
CRITERION ACC. SENSDEM AND SPECDEM ARE SENSITIVITY 
AND SPECIFICITY FOR DEMENTIA CLASS. KAPPA IS THE 
COHEN’S KAPPA STATISTIC. 
Method ACC KAPPA SENSDEM SPECDEM 
eXtreme 
Gradient 
Boosting 
0.91 0.86 0.91 0.96 
Stochastic 
Gradient 
Boosting 
0.91 0.85 0.91 0.96 
Random 
Forest 
0.91 0.85 0.93 0.95 
 
TABLE II. MONTE CARLO 100 EXPERIMENTS: 
AVERAGE RESULTS AND STANDARD DEVIATION (SD) OF 
PERFORMANCES OF THE 3 TOP PERFORMING MODELS 
INCLUDING PERFORMANCES FOR DEMENTIA CLASS 
Method ACC KAPPA AUCDEM SENSDEM SPECDEM 
eXtreme 
Gradient 
Boosting 
0.88 
SD 0.02 
0.8 
SD 0.02 
0.97 
SD 0.01 
0.93  
SD 0.02 
0.94  
SD 0.01 
Stochastic 
Gradient 
Boosting 
0.87 
SD 0.01 
0.8 
SD 0.02 
0.96 
SD 0.01 
0.92  
SD 0.03 
0.95  
SD 0.04 
Random 
Forest 
0.87 
SD 0.01 
0.79 
SD 0.02 
0.96 
SD 0.01 
0.92  
SD 0.03 
0.94  
SD 0.04 
 
TABLE IIII. MONTE CARLO 100 EXPERIMENTS: 
AVERAGE RESULTS AND STANDARD DEVIATION (SD) OF 
PERFORMANCES OF THE 3 TOP PERFORMING MODELS 
INCLUDING PERFORMANCES FOR MCI AND NC CLASSES 
Method SENSMCI SPECMCI SENSNC SPECNC 
eXtreme 
Gradient 
Boosting 
0.86  
SD 0.02 
0.9 
SD 0.02 
0.89  
SD 0.03 
0.96  
SD 0.01 
Stochastic 
Gradient 
Boosting 
0.86  
SD 0.03 
0.89 
SD 0.02 
0.87  
SD 0.03 
0.97  
SD 0.01 
Random 
Forest 
0.86  
SD 0.03 
0.88 
SD 0.02 
0.86 
SD 0.03 
0.97  
SD 0.01 
 
The class-specific performances of the top 3 
models for dementia, such as AUC, sensitivity and 
specificity, as well as the non-specific 
performances accuracy and kappa, are reflected 
also in Figure 2.  
FIGURE 2. BOXPLOTS SHOWING PERFORMANCE RESULTS 
FOR DEMENTIA OF THE TOP 3 MODELS IN MONTE CARLO 
100 EXPERIMENTS 
 
 
 
IV. DISCUSSION AND CONCLUSION 
Several machine learning methods and 
subsequent models were explored in this study. All 
of them were able to recognize patterns 
differentiating the three classes to a certain level, 
which indicate that machine learning does have the 
capacity to accurately predict dementia and mild 
cognitive impairment, and as such further 
exploration of these methods is deemed necessary. 
In this paper these models’ performance variation 
was assessed with Monte Carlo experiments, and 
they consistently yielded adequate predictive power 
and significant model performance stability. The 
best performing model in term o accuracy was 
eXtreme Gradient Boosting, achieving as high as 
91% accuracy in some cases and an average 
performance of 88% accuracy in Monte Carlo 
simulations with 100 repetitions. 
By evaluating the discriminative power of variables 
across models, we found that several features show 
high predictive capabilities. Feature analysis was 
carried out on the training data only and Table IV 
shows the top results of observed Relief score that 
correspond to a p-value lower than 0.1 in the 
permutation test performed with 500 permutations 
of labels. Table V also shows the top results as 
scored by information gain. Although the rank of 
the predictors is not identical, the two methods 
seem to concord significantly in this case. However, 
we tend to value more the ReliefF based procedure 
as the ReliefF method accounts for some interaction 
between features (which Information gain doesn’t), 
and secondly it is combined with a statistical 
permutation test by permuting labels 500 times 
whose impact is a selection of features whose 
observed Relief index is higher than what is 
obtained by randomly re-combining records with 
labels. The downside of this procedure is that it 
becomes more expensive computationally. 
However, compared with the Information gain 
simple method, it led to better results in terms of 
performances of the predictive models. 
TABLE VI. THE TOP 10 FEAUTURES ACCORDING TO 
RELIEFF WITH PRMUTATION TEST, AND INFORMATION 
GAIN METHODS 
Score ReliefF Information gain 
1 mPACCdigit.bl LDELTOTAL.bl 
2 mPACCtrailsB.bl mPACCdigit.bl 
3 LDELTOTAL.bl mPACCtrailsB.bl 
4 ADAS13.bl   MMSE.bl 
5 FAQ.bl FAQ.bl 
6 MMSE.bl ADAS13.bl 
7 ADAS11.bl EcogSPTotal.bl 
8 EcogSPTotal.bl ADASQ4.bl 
9 EcogSPMem.bl ADAS11.bl 
10 EcogSPPlan.bl EcogSPMem.bl 
 
Ongoing work envisages multiple directions for 
extending this work, in particular: (i) translating the 
problem in 2-class classifications and extending the 
methodology with techniques such as ROC cross-
evaluation [8], which also involves model 
optimisation in post-processing, and (ii) utilising 
the best models resulting from this study and from 
its forthcoming extension, in the creation of 
individualized dementia-risk scores. 
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